Doctor Investment Group (“DIG”) collaborates with healthcare companies to strategically position them for acquisition by institutional buyers. Rather than selling individual healthcare practices, DIG focuses on selling companies that offer products or services within the healthcare industry.
To achieve this, DIG develops and implements comprehensive strategies, bringing together affiliated companies that play a role in executing these plans. A key aspect of this approach is demonstrating how a client’s product or service can enhance or simplify the process of selling an individual healthcare practice—or even an entire network of practices. This added value can attract more potential buyers or increase the overall valuation of a practice.
For healthcare providers participating in DIG’s initiatives, this often results in higher valuations for their practices, should they choose to sell. However, selling is never a requirement. Additionally, DIG facilitates direct introductions between its clients and institutional buyers when needed. Rather than charging an upfront fee, DIG earns compensation as a percentage of the final sale upon closing.
DIG reaches out to doctors to invite them to serve as test locations for its clients’ products or services. Typically, DIG implements test sites across 100 different healthcare practices nationwide, generating the data needed to support a client’s business case for acquisition.
For doctors, these opportunities provide a chance to evaluate products and services in a real-world clinical setting while playing a key role in positioning a healthcare company for acquisition. Participation is structured to ensure that doctors:
In many cases, DIG also shares a portion of its earnings from the eventual sale of the client’s company, offering doctors a financial benefit beyond the testing phase. To further protect participants, DIG or the client company may provide additional safeguards to minimize or eliminate any potential risks.
By partnering with DIG, doctors gain access to cutting-edge healthcare innovations while maintaining financial security and professional autonomy.
Yes. Every product or service introduced through DIG is designed to benefit patients and has undergone a thorough vetting process to ensure compliance with CMS (Centers for Medicare & Medicaid Services) and other industry regulations.
Yes, but participation does not require selling a practice. DIG’s primary goal is to generate valuable data that demonstrates the effectiveness, market potential and the increase in valuation realized by a healthcare practice as a result of adding the client’s product or service.
While some practices may choose to explore a sale as part of the process, there is no obligation to do so. Healthcare providers maintain complete control over their decision-making, ensuring that their involvement remains aligned with their professional goals.
By analyzing data from 100 test locations, DIG can demonstrate how integrating a particular system or service increases a practice’s valuation. Institutional buyers are often interested in acquiring companies with proven models that can be scaled across multiple locations.
If you believe your company or product could be positioned for acquisition by an institutional buyer, please complete our contact form. A DIG representative will reach out to explore potential opportunities. We are always seeking innovative healthcare companies to bring to market.